SMS Pharma receives EIR for Bachupally facility
SMS Pharmaceuticals has received establishment inspection report (EIR) for its Bachupally facility in Hyderabad, from the US health regulator. The company in a regulatory filing...
Tag : receives
Grasim receives approval for Rs.2,560 crore expansion project
Grasim Industries has received approval for expanding the production of man made fibre Viscose Staple Fibre (VSF) at Bharuch, Gujarat which requires an investment of Rs.2,560...
BHEL receives power project order in Maharashtra worth Rs.2,800 crore
BHEL has bagged a contract for 660 MW supercritical thermal power project in Maharashtra, worth Rs.2,800 crore. The company in a BSE filing stated that,...
Gayatri Projects receives Rs.923 cr road projects in Odisha
Gayatri Projects has bagged orders for 2 road projects from NHAI in Odisha, worth Rs.923 crore. In a BSE filing the company stated, “Gayatri Projects...
JB Chemicals receives European GMP approval for Gujarat facility
JB Chemicals and Pharmaceuticals has received European Union Regulator approval, for Panoli facility located at Gujarat. The company got European GMP approval for its formulation facilities...
Lupin receives USFDA approval for Tamiflu Capsules
Lupin has received US health regulator’s approval for generic Tamiflu Capsules. The company stated that, it has received final approval for its Oseltamivir Phosphate Capsules...
Aarti Drugs receives board approval for buyback of shares
Aarti Drugs has received approval from the board to buyback shares at a price of Rs.875 per share, through tender offer. The company in a...
Ramco Systems receives order from aerial tour company
Ramco Systems has received an order from world’s largest and longest running aerial tour company, Papillon Grand Canyon Helicopters, to install Ramco Aviation Suite V5.8, for...
Bank of India receives Rs.2,257 crore from government
Bank of India (BOI) has received a capital infusion of Rs.2,257 crore from the government. In a BSE filing the BOI stated, “The bank has on...
Mylan-Biocon’s breast cancer biosimilar receives ANVISA approval
Biocon and Mylan’s proposed trastuzumab has received approval from Brazilian regulatory agency ANVISA, through their partner Libbs Farmaceutica (Libbs). The approved product is co-developed by Biocon...